The global subcutaneous drug delivery devices market is projected to reach a valuation of USD 51.8 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.6% from 2025 to 2030, according to a recent report by Grand View Research, Inc. This robust market expansion is primarily driven by the rising prevalence of chronic health conditions, coupled with the increasing...